Colgate's Sales Growth Potential Offset by Challenging Comps -- Market Talk
Market Climbs as Investors Prepare for Biggest Earnings Week of the Year | Live Stock
DBS Maintains Colgate-Palmolive(CL.US) With Hold Rating, Announces Target Price $104
Colgate-Palmolive: Hold Rating Amid Strong Performance and Limited Upside Potential
Colgate-Palmolive Facing Competitive Comparisons, Softer Organic Sales Growth - Analyst
BofA Securities Maintains Colgate-Palmolive(CL.US) With Buy Rating
Stocks on Sale: Colgate-Palmolive, DexCom, and Realty Income
This Colgate-Palmolive Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
A Quick Look at Today's Ratings for Colgate-Palmolive(CL.US), With a Forecast Between $92 to $112
Colgate-Palmolive Is Maintained at Buy by TD Cowen
Express News | TD Cowen Maintains Buy on Colgate-Palmolive, Lowers Price Target to $110
Colgate-Palmolive Analyst Ratings
Today's Analyst Rating | General Dynamics Price Target Raised to $350 by BofA Securities, Wells Fargo Upgrades Aon PLC to Hold
Evercore ISI Reaffirms Their Buy Rating on Colgate-Palmolive (CL)
Colgate-Palmolive Price Target Lowered to $92 From $100 at Wells Fargo
Redburn Atlantic Adjusts Price Target on Colgate-Palmolive to $99 From $94, Maintains Neutral Rating
Sell Recommendation for Colgate-Palmolive Amid Valuation Normalization and Growth Concerns
Colgate-Palmolive: Hold Rating Amid Growth Challenges and Competitive Pressures
Colgate-Palmolive Downgraded to Hold From Buy at Stifel
Nasdaq Surges To Fresh Highs As Nvidia, Meta And Amazon Surge: Fear Index Remains In 'Greed' Zone